Sign in

CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company

CERENOME, INC.

Sign in to watch
Ticker
CNSY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330827593
Phone
737.255.7194
Business address
6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
Former names
PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
  1. 8-K Event Results of operations
  2. 10-Q Report Quarterly Report
  3. 424B5 Offering Prospectus
  4. 8-K Event Material agreement
  5. 4 Open-market buy Director bought 1,500 shares at an average $5.27 ($7,907)
  6. EFFECT Other Notice of Effectiveness
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Grant or award Director acquired 21,000 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 8-K Event Executive or director change
  12. 4 Derivatives Options or other derivatives
  13. DEF 14A Proxy Proxy Statement
  14. S-3 Offering Registration Statement
  15. 10-K Report Annual Report
  16. 8-K Event Results of operations
  17. 8-K Event Executive or director change
  18. 4 Grant or award President - Asia Pacific acquired 31,825 shares (grant or award)
  19. 4 Grant or award Chief Financial Officer acquired 33,500 shares (grant or award)
  20. 4 Grant or award President acquired 36,850 shares (grant or award)

Page 50 of 74 · 1,465 filings